nih news from FierceHealthcare
News
NIH offers free care to patients with rare illnesses
ALSO NOTED: Healthcare orgs still hiring despite downturn; Data breach affects U.S. Representative; and much more...
ALSO NOTED: TN Medicaid to test e-prescribing program; NIH alerts patients of stolen personal information; and much more...
Study: Number of drug-resistant germs rising
ALSO NOTED: HealthTronics chief dies; PA meth clinics under fire; and much more...
HHS to merge genetic, clinical info
HHS Secretary Mike Leavitt has unveiled a new initiative which would merge genetic and clinical data in an effort to individualize and improve patient care. Leavitt's "Personalized Health Care" program would use the merged data to predict, and hopefully prevent, the onset of many diseases. Leavitt has said that this effort will be one of his top priorities for the next two years. The concept isn't as novel as it may sound--the VA is already combining …
Read more...States seek Lilly help with Zyprexa costs
Concerned about the large and growing cost of antipsychotic drug Zyprexa, a number of states have taken Eli Lilly up on its offer to make sure Medicaid physicians stick to Zyprexa prescribing guidelines. The question, though, is whether states are getting what they're supposed to from these programs.
Zyprexa, which treats bipolar disorder and schizophrenia, generates the biggest single drug cost for state Medicaid programs. These programs spent $1.3 billion on the drug in 2005, …
Read more...New MRI test advantages discovered
In two separate studies this week, evidence has accumulated suggesting that MRI tests have some real advantages in treating cardiovascular incidents. In one study, conducted by researchers at the NIH's National Institute of Neurological Disorders and Stroke, researchers concluded that MRIs are more sensitive that CT scans when it comes to emergency diagnosis of acute ischemic stroke. In a separate piece of research, meanwhile, doctors at Mount Sinai Medical Center said they'd found MRI …
Read more...Lilly accused of promoting off-label Zyprexa use
Has drugmaker Eli Lilly been promoting the off-label use of antipsychotic Zyprexa for elderly patients with dementia symptoms? According to an investigation by The New York Times, Lilly has been doing just that since late 2000, despite FDA rules to the contrary. Materials given to the NYT outline a campaign called Viva Zyprexa, in which sales reps are told to suggest the drug for older dementia patients. However, such marketing would run afoul of FDA rules, as Zyprexa is …
Read more...ALSO NOTED: NIH researcher pleads guilty; Nurse engagement key to quality; and much more...
> Former NIH geriatric psychiatry head Pearson "Trey" Sunderland pleaded guilty this week to violating conflict of interest rules. Sunderland had failed to disclose that he had accepted $285,000 in payments from Pfizer while serving as a researcher at NIH. Article
> …
Read more...Get more nih coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




